Unknown

Dataset Information

0

Structure-Affinity Relationships and Structure-Kinetic Relationships of 1,2-Diarylimidazol-4-carboxamide Derivatives as Human Cannabinoid 1 Receptor Antagonists.


ABSTRACT: We report on the synthesis and biological evaluation of a series of 1,2-diarylimidazol-4-carboxamide derivatives developed as CB1 receptor antagonists. These were evaluated in a radioligand displacement binding assay, a [35S]GTP?S binding assay, and in a competition association assay that enables the relatively fast kinetic screening of multiple compounds. The compounds show high affinities and a diverse range of kinetic profiles at the CB1 receptor and their structure-kinetic relationships (SKRs) were established. Using the recently resolved hCB1 receptor crystal structures, we also performed a modeling study that sheds light on the crucial interactions for both the affinity and dissociation kinetics of this family of ligands. We provide evidence that, next to affinity, additional knowledge of binding kinetics is useful for selecting new hCB1 receptor antagonists in the early phases of drug discovery.

SUBMITTER: Xia L 

PROVIDER: S-EPMC5734604 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Structure-Affinity Relationships and Structure-Kinetic Relationships of 1,2-Diarylimidazol-4-carboxamide Derivatives as Human Cannabinoid 1 Receptor Antagonists.

Xia Lizi L   de Vries Henk H   Lenselink Eelke B EB   Louvel Julien J   Waring Michael J MJ   Cheng Leifeng L   Pahlén Sara S   Petersson Maria J MJ   Schell Peter P   Olsson Roine I RI   Heitman Laura H LH   Sheppard Robert J RJ   IJzerman Adriaan P AP  

Journal of medicinal chemistry 20171121 23


We report on the synthesis and biological evaluation of a series of 1,2-diarylimidazol-4-carboxamide derivatives developed as CB<sub>1</sub> receptor antagonists. These were evaluated in a radioligand displacement binding assay, a [<sup>35</sup>S]GTPγS binding assay, and in a competition association assay that enables the relatively fast kinetic screening of multiple compounds. The compounds show high affinities and a diverse range of kinetic profiles at the CB<sub>1</sub> receptor and their str  ...[more]

Similar Datasets

| S-EPMC5601358 | biostudies-literature
| S-EPMC4492447 | biostudies-literature
| S-EPMC4411897 | biostudies-literature
| S-EPMC8683641 | biostudies-literature
| S-EPMC3616494 | biostudies-literature
| S-EPMC7224360 | biostudies-literature
| S-EPMC3382773 | biostudies-literature
| S-EPMC5063714 | biostudies-other
| S-EPMC4518088 | biostudies-literature
| S-EPMC4459378 | biostudies-literature